Rare diseases
Investigational molecules
Locations
Back to Italy692 clinical trials in Rozzano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
ItalyPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
ItalyEfficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study
ItalyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
ItalyPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
ItalyPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
ItalyStudy of MDX2003 in Adults with Relapsed or Refractory B‑Cell Malignancies
ItalyStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
ItalyLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
ItalyEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
ItalyA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
ItalyThe busiest research cities in the country
What the registry says about research in the country
Critical investigations focusing on various cancer types including metastatic colorectal cancer, acute myeloid leukemia, and advanced breast cancer. Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Multiple trials exploring innovative treatment approaches for both solid tumors and hematological malignancies.
Research initiatives examining treatments for idiopathic pulmonary fibrosis and chronic respiratory conditions. Studies focus on improving lung function and patient quality of life.
Investigations aim to advance therapeutic options for patients with chronic respiratory conditions.
Comprehensive research into conditions like psoriatic arthritis and systemic sclerosis. Studies evaluate new biological treatments and therapeutic approaches.
Trials focus on developing targeted therapies for various inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
